2m 2m 2m 2m 2m 2m 2m
LINEAGE CELL (LCTX)
NYSE
$1.27+$0.02 (+1.60%)
Price as of Jun 23, 2026 6:37 PM EDT- $314.1MMarket Cap
- 31.33%1-Year Change
- BiotechnologyIndustry
LINEAGE CELL (LCTX)
$1.27+$0.02 (+1.60%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13.6M +43.27% | 9.5M +6.19% | 8.9M -39.16% | 14.7M +238.70% | |
Cost of Revenue | N/A N/A | 334,000 -50.22% | 671,000 -7.83% | 728,000 -48.95% | |
Gross Profit | 13.6M +48.49% | 9.2M +10.77% | 8.3M -40.79% | 14.0M +379.42% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -17.7M +42.15% | -12.5M -20.59% | -15.7M -212.28% | 14.0M -58.76% | |
Depreciation and Amortization Expense | 699,000 +19.08% | 587,000 +4.45% | 562,000 +287.59% | 145,000 -30.95% | |
Total Operating Expenses | 51.2M +65.20% | 31.0M -6.15% | 33.0M -9.56% | 36.5M -29.99% | |
Operating Profit | -36.6M +70.50% | -21.5M -13.16% | -24.7M +9.83% | -22.5M -54.24% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 -100.00% | 829,000 +41,350.00% | |
Total Nonoperating Income and Expense | -32.0M -1,205.94% | 2.9M +99.59% | 1.5M +144.08% | -3.3M -155.41% | |
Income before Taxes | -68.6M +269.43% | -18.6M -20.19% | -23.3M -9.80% | -25.8M -40.35% | |
Income Taxes | -5.3M N/A | 0 +100.00% | -1.8M -433.27% | 541,000 N/A | |
Extraordinary Items | N/A N/A | 0 N/A | 0 N/A | N/A N/A | |
Net Income | -63.5M +241.41% | -18.6M -13.39% | -21.5M -18.22% | -26.3M -38.93% | |
Net Income from Continuing Operations Applicable to Common | -68.6M +269.43% | -18.6M -20.19% | -23.3M -9.80% | -25.8M -40.35% | |
Basic EPS and Net Income | -0.28 +211.11% | -0.09 -25.00% | -0.12 -20.00% | -0.15 -42.31% | |
Diluted EPS and Net Income | -0.28 +211.11% | -0.09 -25.00% | -0.12 -20.00% | -0.15 -42.31% | |
Basic Weighted Average Shares | 230.1M +14.95% | 200.2M +15.94% | 172.7M +1.69% | 169.8M +103,115.77% | |
Diluted Weighted Average Shares | 230.1M +14.95% | 200.2M +15.94% | 172.7M +1.69% | 169.8M +103,115.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 40.8M -10.92% | 45.8M +29.19% | 35.4M +212.13% | 11.4M -79.63% | |
Short-Term Investments | 15.0M +643.55% | 2.0M +3,932.00% | 50,000 -99.89% | 46.5M +1,678.29% | |
Cash and Cash Equivalents and Short-Term Investments | 55.8M +16.68% | 47.8M +34.69% | 35.5M -38.67% | 57.9M -0.83% | |
Total Current Assets | 59.2M +16.00% | 51.0M +32.66% | 38.4M -35.93% | 60.0M -46.21% | |
Accumulated Depreciation | 5.7M +29.65% | 4.4M -39.43% | 7.2M +23.73% | 5.8M +10.34% | |
Property and Plant and Equipment and Net | 2.6M +13.99% | 2.3M -52.78% | 4.8M -15.97% | 5.7M +16.44% | |
Total Long-Term Assets | 2.6M +13.99% | 2.3M -52.78% | 4.8M -15.97% | 5.7M +16.44% | |
Total Assets | 112.6M -0.56% | 113.2M +12.08% | 101.0M -18.31% | 123.7M -29.15% | |
Income Taxes Payable | 22,000 -91.94% | 273,000 0.00% | 273,000 -86.85% | 2.1M 0.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.4M -18.67% | 14.0M -22.18% | 18.0M -5.38% | 19.0M -59.71% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 57.9M +157.91% | 22.4M N/A | 0 -100.00% | 2,000 -99.99% | |
Total Liabilities | 69.2M +91.23% | 36.2M -7.15% | 39.0M -24.61% | 51.7M -38.16% | |
Retained Earnings | -467.0M +15.75% | -403.5M +4.84% | -384.9M +5.91% | -363.4M +7.79% | |
Total Stockholders Equity | 44.5M -43.16% | 78.4M +23.59% | 63.4M -13.53% | 73.3M -20.47% | |
Total Shares Outstanding | 243.1M +10.30% | 220.4M +25.96% | 175.0M +2.88% | 170.1M +0.36% | |
Cash Flow | |||||
Cash from Operating Activities | -18.9M -18.07% | -23.1M -19.16% | -28.6M -2,797.45% | 1.1M +104.49% | |
Capital Expenditures | 522,000 -7.61% | 565,000 -16.17% | 674,000 +63.20% | 413,000 +16.67% | |
Cash from Investing Activities | -13.5M +483.06% | -2.3M -104.97% | 46.4M +200.63% | -46.2M -573.67% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 26.9M -24.84% | 35.9M +458.26% | 6.4M +293.57% | 1.6M -95.58% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 96.48% +4.31% | 92.50% -2.68% | 95.05% +41.55% | |
Operating Margin | -269.08% +19.00% | -226.11% -18.23% | -276.50% +80.52% | -153.17% -86.49% | |
Return on Assets | -56.27% +223.92% | -17.37% -9.17% | -19.13% +8.54% | -17.62% -42.15% | |
Return on Equity | -103.36% +293.82% | -26.25% -16.47% | -31.42% -1.00% | -31.74% -30.49% | |
Revenue Growth | 43.27% +598.61% | 6.19% +115.81% | -39.16% -116.41% | 238.70% +73.31% | |
Current Ratio | 5.20 +42.64% | 3.65 +70.46% | 2.14 -32.29% | 3.16 +33.52% | |
Cash Ratio | 3.59 +9.54% | 3.28 +66.01% | 1.97 +229.89% | 0.60 -49.44% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow